{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:20:14Z","timestamp":1794918014271,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41440-025-02216-w","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:12:19Z","timestamp":1746184339000},"page":"2072-2078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Interaction between SGLT2 and the sympathetic nervous system in normal and various cardiovascular metabolic disease states"],"prefix":"10.1038","volume":"48","author":[{"given":"Kenichi","family":"Katsurada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"2216_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1463-1326.2011.01511.x","volume":"14","author":"RA DeFronzo","year":"2012","unstructured":"DeFronzo RA, Davidson JA, Del Prato S. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab. 2012;14:5\u201314.","journal-title":"Diabetes Obes Metab"},{"key":"2216_CR2","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1093\/eurheartj\/ehw110","volume":"37","author":"N Marx","year":"2016","unstructured":"Marx N, McGuire DK. Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus. Eur Heart J. 2016;37:3192\u2013200.","journal-title":"Eur Heart J"},{"key":"2216_CR3","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373:2117\u201328.","journal-title":"N Engl J Med"},{"key":"2216_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377:644\u201357.","journal-title":"N Engl J Med"},{"key":"2216_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381:1995\u20132008.","journal-title":"N Engl J Med"},{"key":"2216_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383:1413\u201324.","journal-title":"N Engl J Med"},{"key":"2216_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385:1451\u201361.","journal-title":"N Engl J Med"},{"key":"2216_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1152\/japplphysiol.00832.2009","volume":"108","author":"M Esler","year":"2010","unstructured":"Esler M. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol. 2010;108:227\u201337.","journal-title":"J Appl Physiol"},{"key":"2216_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jash.2016.02.015","volume":"10","author":"G Grassi","year":"2016","unstructured":"Grassi G, Ram VS. Evidence for a critical role of the sympathetic nervous system in hypertension. J Am Soc Hypertens. 2016;10:457\u201366.","journal-title":"J Am Soc Hypertens"},{"key":"2216_CR10","doi-asserted-by":"publisher","unstructured":"Grassi G, Quarti-Trevano F, Esler MD. Sympathetic activation in congestive heart failure: an updated overview. Heart Fail Rev. 2019. https:\/\/doi.org\/10.1007\/s10741-019-09901-2.","DOI":"10.1007\/s10741-019-09901-2"},{"key":"2216_CR11","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s00125-015-3771-9","volume":"58","author":"K Rafiq","year":"2015","unstructured":"Rafiq K, Fujisawa Y, Sherajee SJ, Rahman A, Sufiun A, Kobori H, et al. Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats. Diabetologia. 2015;58:2885\u201398.","journal-title":"Diabetologia"},{"key":"2216_CR12","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1097\/HJH.0000000000001434","volume":"35","author":"VB Matthews","year":"2017","unstructured":"Matthews VB, Elliot RH, Rudnicka C, Hricova J, Herat L, Schlaich MP. Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2. J Hypertens. 2017;35:2059\u201368.","journal-title":"J Hypertens"},{"key":"2216_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008365","volume":"14","author":"K Katsurada","year":"2021","unstructured":"Katsurada K, Nandi SS, Sharma NM, Patel KP. Enhanced Expression and Function of Renal SGLT2 (Sodium-Glucose Cotransporter 2) in Heart Failure: Role of Renal Nerves. Circ Heart Fail. 2021;14:e008365.","journal-title":"Circ Heart Fail"},{"key":"2216_CR14","doi-asserted-by":"publisher","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","volume":"306","author":"V Vallon","year":"2014","unstructured":"Vallon V, Gerasimova M, Rose MA, Masuda T, Satriano J, Mayoux E, et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am J Physiol Ren Physiol. 2014;306:F194\u2013204.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2216_CR15","doi-asserted-by":"publisher","first-page":"F317","DOI":"10.1152\/ajprenal.00145.2014","volume":"307","author":"F Gembardt","year":"2014","unstructured":"Gembardt F, Bartaun C, Jarzebska N, Mayoux E, Todorov VT, Hohenstein B, et al. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob\/ob type 2 diabetic mice with and without hypertension. Am J Physiol Ren Physiol. 2014;307:F317\u201325.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2216_CR16","doi-asserted-by":"publisher","first-page":"e0179960","DOI":"10.1371\/journal.pone.0179960","volume":"12","author":"W Ji","year":"2017","unstructured":"Ji W, Zhao M, Wang M, Yan W, Liu Y, Ren S, et al. Effects of canagliflozin on weight loss in high-fat diet-induced obese mice. PLoS One. 2017;12:e0179960.","journal-title":"PLoS One"},{"key":"2216_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/HJH.0000000000000871","volume":"34","author":"A Rahman","year":"2016","unstructured":"Rahman A, Kittikulsuth W, Fujisawa Y, Sufiun A, Rafiq K, Hitomi H, et al. Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome. J Hypertens. 2016;34:893\u2013906.","journal-title":"J Hypertens"},{"key":"2216_CR18","doi-asserted-by":"publisher","first-page":"F156","DOI":"10.1152\/ajprenal.00409.2012","volume":"304","author":"V Vallon","year":"2013","unstructured":"Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Ren Physiol. 2013;304:F156\u201367.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2216_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000496617","volume":"142","author":"C Ma","year":"2019","unstructured":"Ma C, de Baaij JHF, Millar PJ, Gault VA, de Galan BE, Bindels RJM, et al. Effect of Dapagliflozin Treatment on the Expression of Renal Sodium Transporters\/Channels on High-Fat Diet Diabetic Mice. Nephron. 2019;142:51\u201360.","journal-title":"Nephron"},{"key":"2216_CR20","doi-asserted-by":"publisher","first-page":"p45","DOI":"10.1159\/000214214","volume":"112","author":"MF Albertoni Borghese","year":"2009","unstructured":"Albertoni Borghese MF, Majowicz MP, Ortiz MC, Passalacqua MdelR, Sterin Speziale NB, Vidal NA. Expression and activity of SGLT2 in diabetes induced by streptozotocin: relationship with the lipid environment. Nephron Physiol. 2009;112:p45\u201352.","journal-title":"Nephron Physiol"},{"key":"2216_CR21","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1681\/ASN.2020071029","volume":"32","author":"FA Borges-Junior","year":"2021","unstructured":"Borges-Junior FA, Silva Dos Santos D, Benetti A, Polidoro JZ, Wisnivesky ACT, Crajoinas RO, et al. Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure. J Am Soc Nephrol. 2021;32:1616\u201329.","journal-title":"J Am Soc Nephrol"},{"key":"2216_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41440-023-01437-1","volume":"47","author":"A Endo","year":"2024","unstructured":"Endo A, Hirose T, Sato S, Ito H, Takahashi C, Ishikawa R, et al. Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion. Hypertens Res. 2024;47:33\u201345.","journal-title":"Hypertens Res"},{"key":"2216_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacbts.2019.11.007","volume":"5","author":"LY Herat","year":"2020","unstructured":"Herat LY, Magno AL, Rudnicka C, Hricova J, Carnagarin R, Ward NC, et al. SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection. JACC Basic Transl Sci. 2020;5:169\u201379.","journal-title":"JACC Basic Transl Sci."},{"key":"2216_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-1838(91)90129-Q","volume":"36","author":"KP Patel","year":"1991","unstructured":"Patel KP. Central alpha-2 adrenergic mechanisms in the renal nerve mediated natriuresis and diuresis produced by acute volume expansion. J Auton Nerv Syst. 1991;36:47\u201354.","journal-title":"J Auton Nerv Syst"},{"key":"2216_CR25","first-page":"R712","volume":"261","author":"DW Zeigler","year":"1991","unstructured":"Zeigler DW, Patel KP. Reduced renal responses to an acute saline load in obese Zucker rats. Am J Physiol. 1991;261:R712\u20138.","journal-title":"Am J Physiol"},{"key":"2216_CR26","first-page":"R383","volume":"274","author":"E Badoer","year":"1998","unstructured":"Badoer E, Moguilevski V, McGrath BP. Cardiac afferents play the dominant role in renal nerve inhibition elicited by volume expansion in the rabbit. Am J Physiol. 1998;274:R383\u20138.","journal-title":"Am J Physiol"},{"key":"2216_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00004872-199003000-00009","volume":"8","author":"RE Widdop","year":"1990","unstructured":"Widdop RE, Verberne AJ, Jarrott B, Louis WJ. Impaired arterial baroreceptor reflex and cardiopulmonary vagal reflex in conscious spontaneously hypertensive rats. J Hypertens. 1990;8:269\u201375.","journal-title":"J Hypertens"},{"key":"2216_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/01.HYP.25.4.814","volume":"25","author":"BS Huang","year":"1995","unstructured":"Huang BS, Leenen FH. Brain \u2018ouabain,\u2019 sodium, and arterial baroreflex in spontaneously hypertensive rats. Hypertension. 1995;25:814\u20137.","journal-title":"Hypertension"},{"key":"2216_CR29","first-page":"R27","volume":"266","author":"GF DiBona","year":"1994","unstructured":"DiBona GF, Sawin LL. Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol. 1994;266:R27\u201339.","journal-title":"Am J Physiol"},{"key":"2216_CR30","doi-asserted-by":"publisher","first-page":"F1148","DOI":"10.1152\/ajprenal.00501.2005","volume":"291","author":"H Zheng","year":"2006","unstructured":"Zheng H, Li YF, Zucker IH, Patel KP. Exercise training improves renal excretory responses to acute volume expansion in rats with heart failure. Am J Physiol Ren Physiol. 2006;291:F1148\u201356.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2216_CR31","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1161\/HYPERTENSIONAHA.122.19177","volume":"79","author":"HK Kim","year":"2022","unstructured":"Kim HK, Ishizawa R, Fukazawa A, Wang Z, Bezan Petric U, Hu MC, et al. Dapagliflozin Attenuates Sympathetic and Pressor Responses to Stress in Young Prehypertensive Spontaneously Hypertensive Rats. Hypertension. 2022;79:1824\u201334.","journal-title":"Hypertension"},{"key":"2216_CR32","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.1016088108","volume":"108","author":"I Kimura","year":"2011","unstructured":"Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci USA. 2011;108:8030\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2216_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35690-z","volume":"8","author":"C Colina","year":"2018","unstructured":"Colina C, Puhl HL 3rd, Ikeda SR. Selective tracking of FFAR3-expressing neurons supports receptor coupling to N-type calcium channels in mouse sympathetic neurons. Sci Rep. 2018;8:17379.","journal-title":"Sci Rep"},{"key":"2216_CR34","doi-asserted-by":"publisher","first-page":"E1205","DOI":"10.1152\/ajpendo.2001.281.6.E1205","volume":"281","author":"A Tardif","year":"2001","unstructured":"Tardif A, Julien N, Pelletier A, Thibault G, Srivastava AK, Chiasson JL, et al. Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am J Physiol Endocrinol Metab. 2001;281:E1205\u201312.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2216_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.phrs.2007.04.006","volume":"55","author":"KT Velazquez","year":"2007","unstructured":"Velazquez KT, Mohammad H, Sweitzer SM. Protein kinase C in pain: involvement of multiple isoforms. Pharm Res. 2007;55:578\u201389.","journal-title":"Pharm Res"},{"key":"2216_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/hr.2017.14","volume":"40","author":"T Yoshikawa","year":"2017","unstructured":"Yoshikawa T, Kishi T, Shinohara K, Takesue K, Shibata R, Sonoda N, et al. Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats. Hypertens Res. 2017;40:646\u201351.","journal-title":"Hypertens Res"},{"key":"2216_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jjcc.2017.12.004","volume":"71","author":"M Sano","year":"2018","unstructured":"Sano M. A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity. J Cardiol. 2018;71:471\u20136.","journal-title":"J Cardiol"},{"key":"2216_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jacbts.2020.01.011","volume":"5","author":"S Verma","year":"2020","unstructured":"Verma S. Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? JACC Basic Transl Sci. 2020;5:180\u20132.","journal-title":"JACC Basic Transl Sci"},{"key":"2216_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2021.101224","volume":"47","author":"V Spallone","year":"2021","unstructured":"Spallone V, Valensi P. SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement. Diabetes Metab. 2021;47:101224.","journal-title":"Diabetes Metab"},{"key":"2216_CR40","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41440-021-00746-7","volume":"44","author":"K Katsurada","year":"2021","unstructured":"Katsurada K, Ogoyama Y, Imai Y, Patel KP, Kario K. Renal denervation based on experimental rationale. Hypertens Res. 2021;44:1385\u201394.","journal-title":"Hypertens Res"},{"key":"2216_CR41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.122.319989","volume":"130","author":"KP Patel","year":"2022","unstructured":"Patel KP, Katsurada K, Zheng H. Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys. Circ Res. 2022;130:1601\u201317.","journal-title":"Circ Res"},{"key":"2216_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.118.11071","volume":"72","author":"H Zheng","year":"2018","unstructured":"Zheng H, Katsurada K, Liu X, Knuepfer MM, Patel KP. Specific Afferent Renal Denervation Prevents Reduction in Neuronal Nitric Oxide Synthase Within the Paraventricular Nucleus in Rats With Chronic Heart Failure. Hypertension. 2018;72:667\u201375.","journal-title":"Hypertension"},{"key":"2216_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01029-0","volume":"19","author":"K Katsurada","year":"2020","unstructured":"Katsurada K, Nandi SS, Zheng H, Liu X, Sharma NM, Patel KP. GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation. Cardiovasc Diabetol. 2020;19:57.","journal-title":"Cardiovasc Diabetol"},{"key":"2216_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/HYPERTENSIONAHA.116.07850","volume":"68","author":"CT Banek","year":"2016","unstructured":"Banek CT, Knuepfer MM, Foss JD, Fiege JK, Asirvatham-Jeyaraj N, Van Helden D, et al. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension. Hypertension. 2016;68:1415\u201323.","journal-title":"Hypertension"},{"key":"2216_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1152\/jn.00173.2019","volume":"122","author":"J Ong","year":"2019","unstructured":"Ong J, Kinsman BJ, Sved AF, Rush BM, Tan RJ, Carattino MD, et al. Renal sensory nerves increase sympathetic nerve activity and blood pressure in 2-kidney 1-clip hypertensive mice. J Neurophysiol. 2019;122:358\u201367.","journal-title":"J Neurophysiol"},{"key":"2216_CR46","doi-asserted-by":"publisher","first-page":"F680","DOI":"10.1152\/ajprenal.00009.2022","volume":"322","author":"MM Gauthier","year":"2022","unstructured":"Gauthier MM, Dennis MR, Morales MN, Brooks HL, Banek CT. Contributions of afferent and sympathetic renal nerves to cystogenesis and arterial pressure regulation in a preclinical model of autosomal recessive polycystic kidney disease. Am J Physiol Ren Physiol. 2022;322:F680\u2013F91.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2216_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.974197","volume":"17","author":"R Tyshynsky","year":"2023","unstructured":"Tyshynsky R, Sensarma S, Riedl M, Bukowy J, Schramm LP, Vulchanova L, et al. Periglomerular afferent innervation of the mouse renal cortex. Front Neurosci. 2023;17:974197.","journal-title":"Front Neurosci"},{"key":"2216_CR48","doi-asserted-by":"publisher","unstructured":"Evans LC, Dayton A, Osborn JW. Renal nerves in physiology, pathophysiology and interoception. Nat Rev Nephrol. 2024. https:\/\/doi.org\/10.1038\/s41581-024-00893-3.","DOI":"10.1038\/s41581-024-00893-3"},{"key":"2216_CR49","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","volume":"146","author":"M Packer","year":"2022","unstructured":"Packer M. Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling\/Autophagy Hypothesis. Circulation. 2022;146:1383\u2013405.","journal-title":"Circulation"},{"key":"2216_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrn1902","volume":"7","author":"PG Guyenet","year":"2006","unstructured":"Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335\u201346.","journal-title":"Nat Rev Neurosci"},{"key":"2216_CR51","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/ajh\/hpaa074","volume":"33","author":"Y Hirooka","year":"2020","unstructured":"Hirooka Y. Sympathetic Activation in Hypertension: Importance of the Central Nervous System. Am J Hypertens. 2020;33:914\u201326.","journal-title":"Am J Hypertens"},{"key":"2216_CR52","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/neup.12665","volume":"40","author":"Y Chiba","year":"2020","unstructured":"Chiba Y, Sugiyama Y, Nishi N, Nonaka W, Murakami R, Ueno M. Sodium\/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains. Neuropathology. 2020;40:482\u201391.","journal-title":"Neuropathology"},{"key":"2216_CR53","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2147\/DMSO.S258593","volume":"13","author":"T Nguyen","year":"2020","unstructured":"Nguyen T, Wen S, Gong M, Yuan X, Xu D, Wang C, et al. Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice. Diabetes Metab Syndr Obes. 2020;13:2781\u201399.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2216_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41440-023-01417-5","volume":"47","author":"N Oshima","year":"2024","unstructured":"Oshima N, Onimaru H, Yamashiro A, Goto H, Tanoue K, Fukunaga T, et al. SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats. Hypertens Res. 2024;47:46\u201354.","journal-title":"Hypertens Res"},{"key":"2216_CR55","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1016\/j.clinthera.2020.09.008","volume":"42","author":"FA Al Hamed","year":"2020","unstructured":"Al Hamed FA, Elewa H. Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke. Clin Ther. 2020;42:e242\u2013e9.","journal-title":"Clin Ther"},{"key":"2216_CR56","doi-asserted-by":"crossref","unstructured":"Pawlos A, Broncel M, Wozniak E, Gorzelak-Pabis P. Neuroprotective Effect of SGLT2 Inhibitors. Molecules. 2021;26:7213.","DOI":"10.3390\/molecules26237213"},{"key":"2216_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-020-01127-z","volume":"19","author":"W Shimizu","year":"2020","unstructured":"Shimizu W, Kubota Y, Hoshika Y, Mozawa K, Tara S, Tokita Y, et al. Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. Cardiovasc Diabetol. 2020;19:148.","journal-title":"Cardiovasc Diabetol"},{"key":"2216_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022637","volume":"10","author":"T Hamaoka","year":"2021","unstructured":"Hamaoka T, Murai H, Hirai T, Sugimoto H, Mukai Y, Inoue O, et al. Different Responses of Muscle Sympathetic Nerve Activity to Dapagliflozin Between Patients With Type 2 Diabetes With and Without Heart Failure. J Am Heart Assoc. 2021;10:e022637.","journal-title":"J Am Heart Assoc"},{"key":"2216_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13300-023-01497-z","volume":"15","author":"Y Takeshita","year":"2024","unstructured":"Takeshita Y, Nomura C, Murai H, Mukai Y, Hirai T, Hamaoka T, et al. Study Protocol for the Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes. Diabetes Ther. 2024;15:269\u201380.","journal-title":"Diabetes Ther"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02216-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02216-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02216-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T22:03:38Z","timestamp":1751839418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02216-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02216-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}